203 related articles for article (PubMed ID: 37998380)
21. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H
J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725
[TBL] [Abstract][Full Text] [Related]
22. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
[TBL] [Abstract][Full Text] [Related]
23. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.
Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S
Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596
[TBL] [Abstract][Full Text] [Related]
24. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
[TBL] [Abstract][Full Text] [Related]
25. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
[TBL] [Abstract][Full Text] [Related]
26. L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.
Ross RA
Trends Pharmacol Sci; 2011 May; 32(5):265-9. PubMed ID: 21367464
[TBL] [Abstract][Full Text] [Related]
27. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors.
Imbernon M; Whyte L; Diaz-Arteaga A; Russell WR; Moreno NR; Vazquez MJ; Gonzalez CR; Díaz-Ruiz A; Lopez M; Malagón MM; Ross RA; Dieguez C; Nogueiras R
Mol Cell Endocrinol; 2014 Mar; 383(1-2):159-69. PubMed ID: 24378736
[TBL] [Abstract][Full Text] [Related]
28. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
[TBL] [Abstract][Full Text] [Related]
29. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
[TBL] [Abstract][Full Text] [Related]
30. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
[TBL] [Abstract][Full Text] [Related]
31. l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.
Robertson-Gray OJ; Walsh SK; Ryberg E; Jönsson-Rylander AC; Lipina C; Wainwright CL
Pharmacol Res Perspect; 2019 Jun; 7(3):e00487. PubMed ID: 31149342
[TBL] [Abstract][Full Text] [Related]
32. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic nigral GPR55 receptors stimulate [
Sánchez-Zavaleta R; Ávalos-Fuentes JA; González-Hernández AV; Recillas-Morales S; Paz-Bermúdez FJ; Leyva-Gómez G; Cortés H; Florán B
Synapse; 2022 Sep; 76(11-12):e22246. PubMed ID: 35831708
[TBL] [Abstract][Full Text] [Related]
34. Expression of GPR55 and either cannabinoid CB
Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
[TBL] [Abstract][Full Text] [Related]
35. The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.
Moreno-Navarrete JM; Catalán V; Whyte L; Díaz-Arteaga A; Vázquez-Martínez R; Rotellar F; Guzmán R; Gómez-Ambrosi J; Pulido MR; Russell WR; Imbernón M; Ross RA; Malagón MM; Dieguez C; Fernández-Real JM; Frühbeck G; Nogueiras R
Diabetes; 2012 Feb; 61(2):281-91. PubMed ID: 22179809
[TBL] [Abstract][Full Text] [Related]
36. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
[TBL] [Abstract][Full Text] [Related]
37. Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.
Yu J; Deliu E; Zhang XQ; Hoffman NE; Carter RL; Grisanti LA; Brailoiu GC; Madesh M; Cheung JY; Force T; Abood ME; Koch WJ; Tilley DG; Brailoiu E
J Biol Chem; 2013 Aug; 288(31):22481-92. PubMed ID: 23814062
[TBL] [Abstract][Full Text] [Related]
38. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
Lauckner JE; Jensen JB; Chen HY; Lu HC; Hille B; Mackie K
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2699-704. PubMed ID: 18263732
[TBL] [Abstract][Full Text] [Related]
39. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
Anavi-Goffer S; Irving AJ; Ross RA
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
[TBL] [Abstract][Full Text] [Related]
40. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Moreno E; Andradas C; Medrano M; Caffarel MM; Pérez-Gómez E; Blasco-Benito S; Gómez-Cañas M; Pazos MR; Irving AJ; Lluís C; Canela EI; Fernández-Ruiz J; Guzmán M; McCormick PJ; Sánchez C
J Biol Chem; 2014 Aug; 289(32):21960-72. PubMed ID: 24942731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
